Ondine Biomedical (LON:OBI) Stock Price Down 0.9% – Time to Sell?

Ondine Biomedical Inc. (LON:OBI)’s stock price traded down 0.9% during mid-day trading on Friday . The stock traded as low as C$8.50 and last traded at C$8.68. 210,553 shares changed hands during mid-day trading, a decline of 26% from the average session volume of 282,975 shares. The stock had previously closed at C$8.75.

Ondine Biomedical Trading Down 0.9%

The firm has a market capitalization of C$4.50 billion, a P/E ratio of -1.24 and a beta of 0.10. The company has a current ratio of 1.36, a quick ratio of 8.26 and a debt-to-equity ratio of 25.95. The stock has a 50 day simple moving average of C$10.97 and a 200-day simple moving average of C$13.09.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.